FI
ONC

Fosun International’s BeOne Medicines Ltd ONC Stock Holding History

Fosun International’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-53,451
Closed -$5.53M – 64
2017
Q3 		$5.53M Hold
53,451
– – 0.55% 27
2017
Q2 		$2.4M Sell
53,451
-161,228
-75% -$6.35M 0.3% 29
2017
Q1 		$7.86M Sell
214,679
-104,571
-33% -$3.81M 0.98% 14
2016
Q4 		$9.69M Buy
+319,250
New +$10M 1.3% 14

Other funds holding ONC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fosun International's ONC Position: Q4 2017 in Review

Fosun International sold out of BeOne Medicines Ltd (ONC) in Q4 2017, closing a stake of 53,451 shares — an estimated $5.53M sold.

Fosun International first reported a position in ONC in Q4 2016 and held it in 4 quarters. The position peaked at $9.69M in Q4 2016. 93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.

  • Fosun International reported no remaining BeOne Medicines Ltd position as of Q4 2017 after selling out during the quarter.
  • Fosun International sold 53,451 BeOne Medicines Ltd shares in Q4 2017, an estimated $5.53M.
  • Fosun International first reported a position in BeOne Medicines Ltd in Q4 2016 and held it in 4 quarters.
  • Fosun International's BeOne Medicines Ltd position peaked at $9.69M in Q4 2016.
  • 93 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2017.

Based on Fosun International's 13F filing for Q4 2017, filed 9 Feb 2018.